SCHEMBL660293

SCHEMBL660293

COCCNC(=O)C1=CN(CC(=O)c2cc(Cl)ccc2Cl)C=CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.46
ALDH1A1 P00352 4/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 2/20 0.43
ALPL P05186 1/20 0.42
PYGL P06737 1/20 0.42
KDM4E B2RXH2 3/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661570 0.80 ALDH1A1 (0.51) HPGDALDH1A1LMNAMAPK1KMT2A
SCHEMBL286985 0.79 SMN1; SMN2 (0.41) HPGDALDH1A1MAPTLMNAMAPK1
SCHEMBL660547 0.77 ALDH1A1 (0.39) ALDH1A1MAPK1HTTMEN1NPC1
SCHEMBL287385 0.77 ALDH1A1 (0.46) HPGDALDH1A1MAPTKDM4EMAPK1
SCHEMBL7808649 0.75 ALDH1A1 (0.42) HPGDALDH1A1MAPTLMNAKDM4E
SCHEMBL661366 0.73 ALDH1A1 (0.41) ALDH1A1KDM4ENPC1RAB9AKMT2A
SCHEMBL661083 0.72 ALDH1A1 (0.39) ALDH1A1MAPTLMNAKDM4EMAPK1
SCHEMBL660255 0.71 ALDH1A1 (0.47) ALDH1A1MAPTLMNAKDM4EMAPK1
SCHEMBL662087 0.70 KMT2A (0.47) ALDH1A1MAPTLMNAKDM4EMAPK1
SCHEMBL286986 0.69 MAPT (0.46) ALDH1A1MAPTLMNAKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT HPGD 202/4885ALDH1A1 676/4885MAPT 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.